stockportfolio.pro
Stocks / AZTA vs CNMD
AZTA vs CNMD
Azenta, Inc. and CONMED Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Azenta, Inc. (AZTA) | CONMED Corporation (CNMD) | |
|---|---|---|
| Market cap | $1.0B | $1.1B |
| Revenue (latest FY) | $593.82M | $1.37B |
| Net income (latest FY) | $-59.50M | $47.05M |
| Revenue growth (5y CAGR) | 8.9% | 9.8% |
| Net margin | -10.0% | 3.4% |
| Return on equity | -3.4% | 4.6% |
| P/E ratio | — | 20.4 |
| Dividend yield | — | 2.2% |
| Profitable years (of last 10) | 6 | 9 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open AZTA — free Open CNMD — freeFrequently asked questions
Which is bigger, AZTA or CNMD?
CONMED Corporation is larger by market capitalization — $1.1B versus $1.0B.
Which grows faster, AZTA or CNMD?
Over the last five fiscal years, CONMED Corporation grew revenue faster — 9.8%/yr versus 8.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.